Monoclonal antibodies: From magic bullet to precision weapon
H Aboul-Ella, A Gohar, AA Ali, LM Ismail… - Molecular …, 2024 - Springer
Monoclonal antibodies (mAbs) are used to prevent, detect, and treat a broad spectrum of
non-communicable and communicable diseases. Over the past few years, the market for …
non-communicable and communicable diseases. Over the past few years, the market for …
Behavioral alterations in long-term Toxoplasma gondii infection of C57BL/6 mice are associated with neuroinflammation and disruption of the blood brain barrier
L Castaño Barrios, AP Da Silva Pinheiro, D Gibaldi… - Plos one, 2021 - journals.plos.org
The Apicomplexa protozoan Toxoplasma gondii is a mandatory intracellular parasite and
the causative agent of toxoplasmosis. This illness is of medical importance due to its high …
the causative agent of toxoplasmosis. This illness is of medical importance due to its high …
N-acetylglucosamine supplementation fails to bypass the critical acetylation of glucosamine-6-phosphate required for Toxoplasma gondii replication and invasion
MP Alberione, V González-Ruiz, O von Rohr… - PLOS …, 2024 - journals.plos.org
The cell surface of Toxoplasma gondii is rich in glycoconjugates which hold diverse and vital
functions in the lytic cycle of this obligate intracellular parasite. Additionally, the cyst wall of …
functions in the lytic cycle of this obligate intracellular parasite. Additionally, the cyst wall of …
[HTML][HTML] Recomendaciones para el diagnóstico y tratamiento de la infección por Toxoplasma gondii
J Espinoza-Rojas, E López-Mora… - Revista chilena de …, 2022 - SciELO Chile
La toxoplasmosis es una de las parasitosis con mayor prevalencia en el mundo. Se asocia
a morbimortalidad perinatal y en población inmunocomprometida. Actualmente se cuenta …
a morbimortalidad perinatal y en población inmunocomprometida. Actualmente se cuenta …
Anti-Toxoplasma gondii Effects of Lipopeptide Derivatives of Lycosin-I
X Liu, P Zhang, Y Liu, J Li, D Yang, Z Liu, L Jiang - Toxins, 2023 - mdpi.com
Toxoplasmosis, caused by Toxoplasma gondii (T. gondii), is a serious zoonotic parasitic
disease. We previously found that Lycosin-I exhibited anti-T. gondii activity, but its serum …
disease. We previously found that Lycosin-I exhibited anti-T. gondii activity, but its serum …
Investigation of Antiparasitic Effects of Eisenia fetida Extract (Annelida, Lumbricidae) against Toxoplasma gondii: In vitro Study
M Pirestani, H Sobati… - Current Traditional …, 2022 - ingentaconnect.com
Background: Toxoplasmosis, which is caused by Toxoplasma gondii, is a widespread
parasitic disease that affects approximately one-third of the world's population. Due to the …
parasitic disease that affects approximately one-third of the world's population. Due to the …
Recomendaciones para el diagnóstico y tratamiento de la infección por Toxoplasma gondii
RC Choappa, JD Peña, EL Mora, JE Rojas - Revista Chilena de …, 2022 - revinf.cl
La toxoplasmosis es una de las parasitosis con mayor prevalencia en el mundo. Se asocia
a morbimortalidad perinatal y en población inmunocomprometida. Actualmente se cuenta …
a morbimortalidad perinatal y en población inmunocomprometida. Actualmente se cuenta …
[图书][B] Development of Picolinic Acid-derived Anti-parasitics and Methods for the Synthesis of Ring-fused Quinazolin-and Quinolin-ones
MM Khalifa - 2020 - search.proquest.com
As part of a research program at the interface of synthetic organic chemistry and drug
discovery, the Golden lab is interested in new methodology development for heterocycle …
discovery, the Golden lab is interested in new methodology development for heterocycle …